Guardant Health, Inc. (GH)Â
Trading
Quantity
Profitability
Ownership
Largest Insider Buys in Sector
GH Insider Trading Activity
GH Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $0 | 0 | 0 |
Sells | $798,233 | 12 | 100 |
Related Transactions
| Joyce Meghan V. | director | 0 | $0 | 4 | $97,243 | $-97,243 |
| Tariq Musa | director | 0 | $0 | 5 | $100,277 | $-100,277 |
| CLARK IAN T | director | 0 | $0 | 1 | $244,930 | $-244,930 |
| Kalia Kumud | Chief Information Officer | 0 | $0 | 2 | $355,782 | $-355,782 |
About Guardant Health, Inc.
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a clinical-genomic liquid biopsy dataset of advanced cancer patients. It is also developing LUNAR-2 test for the early detection of colorectal cancer in asymptomatic individuals eligible; and GuardantConnect, an integrated software-based solution for clinical and biopharmaceutical customers seeking to connect patients tested with the Guardant360 assay with actionable alterations with potentially relevant clinical trials. In addition, the company offers Guardant Reveal Test for neoadjuvant and adjuvant treatment selection in early-stage cancer patients; Guardant360 tissue genotyping product; and Guardant-19 for use in the detection of the novel coronavirus. Further, it offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, and kits fulfillment related services to biopharmaceutical companies and medical institutions. The company was incorporated in 2011 and is headquartered in Redwood City, California.
Insider Activity of Guardant Health, Inc.
Over the last 12 months, insiders at Guardant Health, Inc. have bought $0 and sold $798,233 worth of Guardant Health, Inc. stock.
On average, over the past 5 years, insiders at Guardant Health, Inc. have bought $8.18M and sold $424.74M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 2,187 shares for transaction amount of $38,963 was made by Kalia Kumud (Chief Information Officer) on 2024‑03‑18.
List of Insider Buy and Sell Transactions, Guardant Health, Inc.
| 2025-03-19 | Sale | Tariq Musa | director | 116 <0.0001% | $43.70 | $5,069 | +0.09% | |
| 2025-03-17 | Sale | Kalia Kumud | Chief Information Officer | 3,500 0.0029% | $43.16 | $151,060 | +7.62% | |
| 2025-03-03 | Sale | Joyce Meghan V. | director | 100 <0.0001% | $42.71 | $4,271 | +5.29% | |
| 2025-02-20 | Sale | Tariq Musa | director | 116 <0.0001% | $48.33 | $5,606 | -12.47% | |
| 2025-01-17 | Sale | Tariq Musa | director | 116 <0.0001% | $37.58 | $4,359 | +23.10% | |
| 2024-12-18 | Sale | Tariq Musa | director | 116 0.0001% | $34.85 | $4,043 | +32.56% | |
| 2024-12-13 | Sale | Tariq Musa | director | 2,320 0.0019% | $35.00 | $81,200 | +22.73% | |
| 2024-12-02 | Sale | Joyce Meghan V. | director | 100 <0.0001% | $35.90 | $3,590 | +17.64% | |
| 2024-11-18 | Sale | Kalia Kumud | Chief Information Officer | 7,000 0.0057% | $29.25 | $204,722 | +38.81% | |
| 2024-11-13 | Sale | Joyce Meghan V. | director | 2,896 0.0022% | $29.90 | $86,595 | +22.48% | |
| 2024-11-12 | Sale | CLARK IAN T | director | 8,318 0.0067% | $29.45 | $244,930 | +28.19% | |
| 2024-06-04 | Sale | Joyce Meghan V. | director | 100 <0.0001% | $27.87 | $2,787 | +10.68% | |
| 2024-03-18 | Kalia Kumud | Chief Information Officer | 2,187 0.0018% | $17.82 | $38,963 | +66.30% | ||
| 2024-03-04 | Sale | Joyce Meghan V. | director | 100 <0.0001% | $19.05 | $1,905 | +50.16% | |
| 2023-12-04 | Sale | Joyce Meghan V. | director | 100 <0.0001% | $26.34 | $2,634 | -7.65% | |
| 2023-12-01 | Sale | Kalia Kumud | Chief Information Officer | 5,800 0.0049% | $26.37 | $152,954 | -5.92% | |
| 2023-09-12 | Sale | Kalia Kumud | Chief Information Officer | 2,125 0.0018% | $32.59 | $69,254 | -20.77% | |
| 2023-09-05 | Sale | Joyce Meghan V. | director | 100 <0.0001% | $35.01 | $3,501 | -26.56% | |
| 2023-06-15 | Sale | Joyce Meghan V. | director | 2,766 0.0027% | $37.55 | $103,863 | -31.15% | |
| 2023-06-09 | Kalia Kumud | Chief Information Officer | 2,981 0.0029% | $32.71 | $97,498 | -20.75% |
Insider Historical Profitability
| Kalia Kumud | Chief Information Officer | 19720 0.016% | $916,191.20 | 2 | 7 | +22.77% |
| CLARK IAN T | director | 8435 0.0068% | $391,890.10 | 0 | 40 | |
| Joyce Meghan V. | director | 7647 0.0062% | $355,279.62 | 0 | 8 | |
| Tariq Musa | director | 3211 0.0026% | $149,183.06 | 0 | 5 | |
| SOFTBANK VISION FUND (AIV M1) L.P. | 10 percent owner | 27850460 22.5654% | $1.29B | 1 | 0 | +5.91% |
| SVF Bluebird (Cayman) Ltd | 10 percent owner | 7037960 5.7024% | $326.98M | 0 | 4 | |
| Eltoukhy Helmy | Co-Chief Executive Officer | 2049238 1.6604% | $95.21M | 4 | 37 | <0.0001% |
| Talasaz AmirAli | Co-Chief Executive Officer | 1902345 1.5413% | $88.38M | 4 | 48 | <0.0001% |
| Wiley Michael J | Chief Legal Officer | 111171 0.0901% | $5.17M | 0 | 13 | |
| Lanman Richard B. | Chief Medical Officer | 82015 0.0665% | $3.81M | 0 | 7 | |
| Merrill Amelia | SVP, People | 20208 0.0164% | $938,863.68 | 0 | 1 | |
| Kaul Samir | director | 14943 0.0121% | $694,251.78 | 0 | 7 | |
| BERTOCCI DEREK A | Chief Financial Officer | 6373 0.0052% | $296,089.58 | 0 | 11 | |
| MERESMAN STANLEY J | 4059 0.0033% | $188,581.14 | 0 | 36 | ||
| Nishar Dipchand | director | 2321 0.0019% | $107,833.66 | 0 | 1 |
GH Institutional Investors: Active Positions
| Increased Positions | 162 | +54.92% | 13M | +10.3% |
| Decreased Positions | 121 | -41.02% | 21M | -16.31% |
| New Positions | 67 | New | 3M | New |
| Sold Out Positions | 32 | Sold Out | 5M | Sold Out |
| Total Postitions | 336 | +13.9% | 121M | -6.01% |
GH Ownership Change vs Market
Institutional Investor Ownership
| Vanguard Group Inc | $555,623.00 | 9.8% | 12.05M | +350,606 | +3% | 2024-12-31 |
| Blackrock, Inc. | $539,443.00 | 9.51% | 11.7M | +266,023 | +2.33% | 2024-12-31 |
| Deep Track Capital, Lp | $295,942.00 | 5.22% | 6.42M | +419,006 | +6.98% | 2024-12-31 |
| Baillie Gifford & Co | $251,204.00 | 4.43% | 5.45M | -422,924 | -7.2% | 2024-12-31 |
| Cadian Capital Management, Lp | $240,714.00 | 4.25% | 5.22M | -2M | -24.66% | 2024-12-31 |
| Wellington Management Group Llp | $223,597.00 | 3.94% | 4.85M | -5M | -52.11% | 2024-12-31 |
| Capital International Investors | $206,216.00 | 3.64% | 4.47M | 0 | 0% | 2024-12-31 |
| Eventide Asset Management, Llc | $175,546.00 | 3.1% | 3.81M | -29,363 | -0.77% | 2024-12-31 |
| State Street Corp | $131,344.00 | 2.32% | 2.85M | +54,738 | +1.96% | 2024-12-31 |
| Braidwell Lp | $131,290.00 | 2.32% | 2.85M | -494,193 | -14.79% | 2024-12-31 |